Whenever a pilot is prescribed or stops using either a new dosage of a medication or a new medication, the pilot must submit that information within 10 days to the physician appointed by the Board of Pilot Commissioners who has the pilot's prescribed medication list (that was previously submitted to the same Board of Pilot Commissioners appointed physician for the pilot's physical examination determining fitness for duty). Whenever the physician receives the updated information, the physician must determine whether the medication change affects the pilot's fitness for duty.
A provider of health care or a health care service plan may disclose medical information in the following circumstances: 1) to other healthcare providers to facilitate diagnosis and treatment 2) to find financially liable party and obtain payment 3) to administrative subcontractors 4) quality control organizations (peer review boards, etc.) 5) accrediting agencies 6) coroners 7) \bona fide research purposes\" 8) employer
Upon a request to the Board of Pilot Commissioners by a federal, state, or local law enforcement agency, the executive director shall make available to the requesting agency any information contained in the board's records.
In order to contract with the department the independent medical review organization must demonstrate that it has a quality assurance mechanism in place that ensures the confidentiality of medical records and the review materials that is consistent with the requirements of applicable laws.
Residential care facilities shall remove resident with health condition who cannot be cared for within limits of license or requires inpatient health facility care. Resident has right to a review by an interdisciplinary team and to a hearing based on regulations for relocation decisions and review.
Every health care service plan shall provide an external, independent review process to examine the plan's coverage decisions regarding experimental or investigational therapies for individual enrollees with a life-threatening or seriously debilitating condition. The enrollee's physician must certify that the enrollee has a condition for which standard therapies are not effective or medically appropriate; the physician certification shall include a statement of the evidence relied upon by the physician in certifying his or her recommendation.
An independent medical review organization contracting with the Department of Managed Health Care shall demonstrate that it has a quality assurance mechanism in place to ensure confidentiality of medical records it reviews.
Upon obtaining the approval from the State Board of Pharmacy and the Department of Justice, a pharmacy or hospital may receive electronic data transmission prescriptions or computer entry prescriptions or orders for Schedule II, III, IV, or V controlled substances if authorized by federal law and consistent with DEA regulations. The Board must maintain a list of all requests and approvals made pursuant to this provision.
Upon notice from the department that an enrollee has applied for an independent medical review, the plan or its contracting providers shall provide the requisite medical records (specified in (1) to (3)) to the independent medical review organization within 3 days. The confidentiality of any enrollee information shall be maintained in accordance with applicable laws.
The Veterinary Medical Board has the authority to place a licensee or registrant on probation. The board may require the licensee or registrant to submit to a complete diagnostic examination by board-appointed physicians. Accordingly, if the board requires a licensee or registrant to submit to that examination, the board shall receive and consider any other report of a complete diagnostic examination given by physicians chosen by the licensee or registrant.